Effect of losartan on kidneys
Pro Research Analysisby 
Searched over 200M research papers
The Effect of Losartan on Kidney Health
Introduction to Losartan and Kidney Health
Losartan, an angiotensin II receptor antagonist, is widely used to manage hypertension and protect kidney function, particularly in patients with diabetes and chronic kidney disease (CKD). This article synthesizes research findings on the effects of losartan on renal outcomes, highlighting its benefits and mechanisms of action.
Losartan and Diabetic Nephropathy
Renal Benefits in Type 2 Diabetes
Losartan has been shown to confer significant renal benefits in patients with type 2 diabetes and nephropathy. In a large randomized study, losartan reduced the incidence of a doubling of serum creatinine concentration by 25% and end-stage renal disease (ESRD) by 28% compared to placebo, without affecting the mortality rate . Additionally, losartan significantly decreased proteinuria by 35%, indicating its protective effect on kidney function beyond blood pressure control .
Uric Acid Reduction and Renal Protection
Emerging data suggest that losartan's ability to lower serum uric acid (SUA) levels contributes to its renoprotective effects. A post hoc analysis revealed that reductions in SUA during losartan therapy were associated with a decreased risk of renal events, such as doubling of serum creatinine or ESRD. This suggests that approximately one-fifth of losartan's renoprotective effect could be attributed to its impact on SUA levels .
Losartan in Non-Diabetic Nephropathy
Comparison with Amlodipine
In hypertensive patients with non-diabetic nephropathy, losartan has been found to reduce proteinuria significantly, whereas amlodipine did not show such an effect. This reduction in proteinuria is crucial for slowing the progression of kidney disease . Furthermore, losartan decreased the filtration fraction, indicating improved renal hemodynamics, while amlodipine did not .
Renal Transplant Recipients
Losartan also shows promise in renal transplant recipients. A study comparing losartan with carvedilol found that losartan significantly reduced albuminuria, a marker of kidney injury, without affecting serum creatinine or cyclosporine levels. This suggests that losartan can be safely used to protect kidney function in transplant patients .
Mechanisms of Renal Protection
Anti-Inflammatory and Anti-Fibrotic Effects
Losartan's renoprotective effects are partly due to its ability to reduce inflammation and fibrosis. In renal transplant patients, losartan significantly lowered plasma levels of transforming growth factor-beta1 (TGF-beta1), a key cytokine involved in fibrosis, while amlodipine did not . This reduction in TGF-beta1 levels helps prevent chronic allograft nephropathy and other fibrotic kidney diseases.
Protection Against Ischemic/Reperfusion Injury
Losartan has also been shown to protect against ischemic/reperfusion (I/R) injury, a major cause of acute kidney injury. In animal studies, losartan administration before and after I/R injury significantly decreased serum markers of kidney damage and oxidative stress, suggesting its potential in acute kidney injury management .
Conclusion
Losartan offers significant renal protection in various forms of kidney disease, including diabetic nephropathy, non-diabetic nephropathy, and in renal transplant recipients. Its benefits extend beyond blood pressure control, involving mechanisms such as reduction of proteinuria, lowering of serum uric acid, and anti-inflammatory and anti-fibrotic effects. These findings underscore the importance of losartan in the management of kidney health, making it a valuable therapeutic option for patients at risk of renal disease.
Sources and full results
Most relevant research papers on this topic
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
Losartan significantly reduces the risk of kidney damage and end-stage renal disease in patients with type 2 diabetes and nephropathy, while maintaining overall cardiovascular health.
The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan
Allicin and losartan both have beneficial effects in chronic kidney disease, reducing hypertension, oxidative stress, and improving renal dysfunction.
Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
Losartan, but not amlodipine, decreased albumin excretion in hypertensive patients with non-diabetic nephropathy.
DOI